---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-001949"
form_type: "8-K"
ticker: "VXRT"
cik: "0000072444"
company_name: "Vaxart, Inc."
filed_at: "2025-01-28T23:59:59+00:00"
generated_at: "2026-05-27T08:43:30.563896+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vaxart appoints Kevin Finney to board; Robert Yedid resigns

## Summary
- Kevin Finney appointed to Vaxart board effective Jan 28, 2025; will serve on Audit and Nominating/Governance committees.
- Robert A. Yedid resigned from board on Jan 28, 2025 for personal reasons; no disagreement with the company.
- Elaine J. Heron appointed to Compensation Committee effective Jan 28, 2025.
- Finney is CEO/President of Autobahn Therapeutics and brings 35 years of biotech leadership experience.

## SEC filing metadata
- accession: 0001437749-25-001949
- form_type: 8-K
- ticker: VXRT
- cik: 0000072444
- company_name: Vaxart, Inc.
- filed_at: 2025-01-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72444/000143774925001949/0001437749-25-001949-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72444/000143774925001949/vxrt20250127_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-001949
- JSON: https://secwatch.observer/filing/0001437749-25-001949.json
- Plain text: https://secwatch.observer/filing/0001437749-25-001949.txt

## Key facts
- Executive change
  Robert A. Yedid resigned as Director at Vaxart, Inc..
  - Action: resigned
  - Role: Director
  source text: Robert A. Yedid resigned from the Board and any committees of the Board, effective January 28, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/72444/000143774925001949/0001437749-25-001949-index.htm
- Executive change
  Kevin Finney was appointed as Director at Vaxart, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board appointed Kevin Finney to serve on the Board, effective January 28, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/72444/000143774925001949/0001437749-25-001949-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.